Literature DB >> 6624950

Vasopressin in blood and third ventricle CSF of dogs in chronic experiments.

C Simon-Oppermann, D Gray, E Szczepańska-Sadowska, E Simon.   

Abstract

A device for chronic implantation was developed that allowed sampling of cerebrospinal fluid (CSF) from the anterior part of the third cerebral ventricle (A3V) of dogs in repeated experiments for up to 4 mo. Osmolalities, electrolyte concentrations, and concentrations of arginine vasopressin (AVP) measured with a radioimmunoassay were determined in repeated experiments on the chronically prepared animals under conditions of normal hydration, both in the conscious state and during inhalation anesthesia. In conscious dogs, AVP concentrations in plasma and CSF were 3.3 +/- 0.4 and 21.8 +/- 2.5 pg X ml-1, respectively. During anesthesia without surgical interference, the AVP concentrations in plasma and CSF were increased twofold above the levels obtained in conscious dogs. During the time of observation (180 min) all measured parameters remained constant. The AVP concentrations in plasma and CSF samples collected during the surgical procedure of device implantation were about 10-fold higher than in the samples collected during the conscious state. Thus, in each experimental condition, AVP concentration in the CSF collected from the A3V was consistently higher than that in the simultaneously collected blood samples.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6624950     DOI: 10.1152/ajpregu.1983.245.4.R541

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Plasma and cerebrospinal fluid vasopressin and osmolality in relation to thirst.

Authors:  E Szczepańska-Sadowska; C Simon-Oppermann; D A Gray; E Simon
Journal:  Pflugers Arch       Date:  1984-03       Impact factor: 3.657

2.  Systemic salt loading decreases body temperature and increases heat-escape/cold-seeking behaviour via the central AT1 and V1 receptors in rats.

Authors:  Masahiro Konishi; Kei Nagashima; Kazuyuki Kanosue
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

3.  Thyrotropin-releasing hormone does not inhibit lysine vasopressin-induced growth hormone secretion in normal men.

Authors:  G Rossi; V Coiro; L Camellini; D Pignatti; C Davoli; B Lari; R Volpi; P Chiodera
Journal:  Experientia       Date:  1985-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.